Brief Article
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2013; 19(43): 7766-7771
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7766
Figure 3
Figure 3 Histopathology of intestinal allograft from recipient rats. Treatment with PU.1 small interference RNA (siRNA) prevents allograft rejection and is associated with mild lymphocyte infiltration and villous damage. Samples from the three groups were compared (magnification × 40, scale bar 20 μm). A: The siRNA PU.1 group; B: The siRNA NC group; C: The control group.